![Takashi Matsumoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takashi Matsumoto
Direktor/Vorstandsmitglied bei DAIICHI SANKYO CO., LTD.
Ursprung des Netzwerks ersten Grades von Takashi Matsumoto
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 61 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Takashi Matsumoto
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
The Robert Wood Johnson Foundation
![]() The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Sumitomo Life Insurance Co.
![]() Sumitomo Life Insurance Co. Life/Health InsuranceFinance Sumitomo Life Insurance Co. engages in the provision of life insurance services. It also sells investment trust and manages defined contribution pension plans. The company was founded in May 1907 and is headquartered in Osaka, Japan. | Life/Health Insurance | Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medocity, Inc.
![]() Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
AJINOMOTO CO., INC. | Food: Specialty/Candy | Director/Board Member | |
FUJIMORI KOGYO CO., LTD. | Industrial Specialties | Director/Board Member | |
MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Keio University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Nippon Wellcome Kk
![]() Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Osaka University | College/University | Graduate Degree | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin | |
Stony Brook University | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
University of Connecticut | College/University | Corporate Officer/Principal | |
University of Hitotsubashi | College/University | Undergraduate Degree | |
University of Tokyo | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Tokyo Medical & Dental University | College/University | Doctorate Degree | |
Sanofi-Aventis Ltd.
![]() Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Society of Japanese Aerospace Companies | Chairman | ||
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
![]() Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President President | |
Japan Vocational Ability Development Association | Chairman | ||
Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd.
![]() Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. is based in Beijing, China. Part of Fosun International Holdings Ltd., Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. is a Chinese company that manufactures and markets pharmaceuticals. The company was founded in 1998. Daiichi Sankyo Pharmaceutical (Beijing) Co. was acquired by Chongqing Yao Pharmaceutical Co., Ltd. from Daiichi Sankyo Co., Ltd. on August 31, 2022. | Pharmaceuticals: Major | Director/Board Member | |
SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Spotlight Therapeutics, Inc.
![]() Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member | |
Neurogene, Inc.
![]() Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Daiichi Sankyo Biotech Co. Ltd. | Chairman | ||
St. Luke's SRL Advanced Clinical Research Center, Inc.
![]() St. Luke's SRL Advanced Clinical Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services St. Luke's SRL Advanced Clinical Research Center, Inc. engages in specimen inspection, research support for clinical examinations, surveys, research and examinations related to treatment and prevention of disease and information provision activities. The company was founded on April 3, 2017 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
SalioGen Therapeutics, Inc.
![]() SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
![]() Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 25 |
Japan | 20 |
Vereinigtes Königreich | 4 |
Schweiz | 3 |
Indien | 2 |
Sektoral
Health Technology | 24 |
Consumer Services | 12 |
Finance | 6 |
Health Services | 4 |
Electronic Technology | 2 |
Operativ
Director/Board Member | 108 |
Corporate Officer/Principal | 61 |
Independent Dir/Board Member | 32 |
Chairman | 26 |
President | 17 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Kazuaki Kama | 15 |
Sukumar Nagendran | 15 |
Sawako Nohara | 13 |
Takashi Okimoto | 10 |
Hiroshi Hirabayashi | 10 |
Kunio Ishihara | 10 |
Antoine Yver | 9 |
Jay Feingold | 7 |
Tsuguya Fukui | 7 |
Susan Romanus | 6 |
Yoshifumi Nishikawa | 6 |
Francis Plat | 6 |
Hiroshi Toda | 6 |
Noritaka Uji | 6 |
Takashi Shoda | 6 |
- Börse
- Insiders
- Takashi Matsumoto
- Unternehmensverbindungen